ETROLIZUMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Fri Dec 15 19:51:57 GMT 2023` Edited by `admin` on `Fri Dec 15 19:51:57 GMT 2023`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG1
Sequence Origin	HUMANIZED RAT
Sequence Type	COMPLETE
Record UNII	I2A72G2V3J
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

ETROLIZUMAB

Official Name

English

ETROLIZUMAB [USAN]

Common Name

English

RHUMAB BETA7

Code

English

RHUMABBETA7

Code

English

IMMUNOGLOBULIN G1, ANTI-(HUMAN INTEGRIN .ALPHA.4.BETA.7/INTEGRIN .ALPHA.E.BETA.7) (HUMAN-RAT MONOCLONAL RHUMAB BETA7 HEAVY CHAIN), DISULFIDE WITH HUMAN-RAT MONOCLONAL RHUMAB BETA7 LIGHT CHAIN, DIMER

Common Name

English

etrolizumab [INN]

Common Name

English

ANTI-.BETA.7

Common Name

English

PRO145223

Code

English

RHUMAB-BETA7

Code

English

PRO-145223

Code

English

Etrolizumab [WHO-DD]

Common Name

English

ANTI-BETA7

Code

English

RHUMAB .BETA.7

Code

English

Classification Tree Code System Code

NCI_THESAURUS

C20401

Created by admin on Fri Dec 15 19:51:57 GMT 2023 , Edited by admin on Fri Dec 15 19:51:57 GMT 2023

FDA ORPHAN DRUG

531116

Created by admin on Fri Dec 15 19:51:57 GMT 2023 , Edited by admin on Fri Dec 15 19:51:57 GMT 2023

FDA ORPHAN DRUG

531216

Created by admin on Fri Dec 15 19:51:57 GMT 2023 , Edited by admin on Fri Dec 15 19:51:57 GMT 2023

Code System Code Type Description

CAS

1044758-60-2

Created by admin on Fri Dec 15 19:51:57 GMT 2023 , Edited by admin on Fri Dec 15 19:51:57 GMT 2023

PRIMARY

DRUG BANK

DB12189

Created by admin on Fri Dec 15 19:51:57 GMT 2023 , Edited by admin on Fri Dec 15 19:51:57 GMT 2023

PRIMARY

WIKIPEDIA

ETROLIZUMAB

Created by admin on Fri Dec 15 19:51:57 GMT 2023 , Edited by admin on Fri Dec 15 19:51:57 GMT 2023

PRIMARY

FDA UNII

I2A72G2V3J

Created by admin on Fri Dec 15 19:51:57 GMT 2023 , Edited by admin on Fri Dec 15 19:51:57 GMT 2023

PRIMARY

ChEMBL

CHEMBL1743015

Created by admin on Fri Dec 15 19:51:57 GMT 2023 , Edited by admin on Fri Dec 15 19:51:57 GMT 2023

PRIMARY

NCI_THESAURUS

C97944

Created by admin on Fri Dec 15 19:51:57 GMT 2023 , Edited by admin on Fri Dec 15 19:51:57 GMT 2023

PRIMARY

EVMPD

SUB75320

Created by admin on Fri Dec 15 19:51:57 GMT 2023 , Edited by admin on Fri Dec 15 19:51:57 GMT 2023

PRIMARY

USAN

WW-80

Created by admin on Fri Dec 15 19:51:57 GMT 2023 , Edited by admin on Fri Dec 15 19:51:57 GMT 2023

PRIMARY

INN

9290

Created by admin on Fri Dec 15 19:51:57 GMT 2023 , Edited by admin on Fri Dec 15 19:51:57 GMT 2023

PRIMARY

From	To
1_22	1_95
1_144	1_200
1_261	1_321
1_367	1_425
2_22	2_95
2_144	2_200
2_261	2_321
2_367	2_425
3_23	3_88
3_134	3_194
4_23	4_88
4_134	4_194
1_220	3_214
2_220	4_214
1_226	2_226
1_229	2_229

Glycosylation Link Type	Site
N	1_297
N	2_297

Related Record Type Details


					JI0F7SK9PX

INTEGRIN ALPHA-4 BETA-7

TARGET -> INHIBITOR

Amount:

Related Record Type Details


					I2A72G2V3J

ACTIVE MOIETY

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL
Molecular Formula	CHEMICAL